ID

42477

Beschreibung

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01212757

Link

https://clinicaltrials.gov/show/NCT01212757

Stichworte

Versionen (1)
  1. 17.07.21 17.07.21 -
Rechteinhaber

Amgen

Hochgeladen am

17. Juli 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Psoriatic Arthritis NCT01212757

Englisch

Eligibility Psoriatic Arthritis NCT01212757

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
males or females, aged ≥ 18 years at time of consent.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
have a diagnosis of psoriatic arthritis (psa, by any criteria) of ≥ 6 months duration.
Beschreibung

Diagnosis od psoriatic arthritis, duration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003872
UMLS CUI [1,2]
C0449238
meet the classification criteria for psoriatic arthritis (caspar) psa at time of screening.
Beschreibung

Classification criteria for psoriatic arthritis (caspar) psa.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003872
UMLS CUI [1,2]
C0008902
UMLS CUI [1,3]
C1550543
must have been inadequately treated by disease-modifying antirheumatic drugs (dmards)
Beschreibung

Treatment procedure, inadequate, disease-modifying antirheumatic drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0242708
UMLS CUI [1,3]
C0205412
may not have axial involvement alone
Beschreibung

Not only axial involvement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0475264
UMLS CUI [1,2]
C0205131
UMLS CUI [1,3]
C1548966
UMLS CUI [1,4]
C0332197
concurrent treatment allowed with methotrexate, leflunomide, or sulfasalazine
Beschreibung

Concurrent treatment allowed with methotrexate, leflunomide, or sulfasalazine

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C2347852
UMLS CUI [2,1]
C0063041
UMLS CUI [2,2]
C2347852
UMLS CUI [3,1]
C0036078
UMLS CUI [3,2]
C2347852
have ≥ 3 swollen and ≥ 3 tender joints.
Beschreibung

Swollen joints quantity, Tender joints quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0152031
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0240094
UMLS CUI [1,4]
C1265611
males & females must use contraception
Beschreibung

Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
stable dose of nonsteroidal anti-inflammatory drugs (nsaids), narcotics and low dose oral corticosteroids allowed.
Beschreibung

Stable dose of nonsteroidal anti-inflammatory drugs (nsaids), narcotics and low dose oral corticosteroids allowed.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003211
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0027415
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0038317
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0445550
UMLS CUI [3,4]
C1527415
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast feeding.
Beschreibung

Pregnancy | Breast feeding.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
history of allergy to any component of the investigational product.
Beschreibung

History of allergy to any component of the investigational product.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0020517
UMLS CUI [1,3]
C1705248
UMLS CUI [1,4]
C0304229
hepatitis b surface antigen and/or hepatitis c antibody positive at screening.
Beschreibung

Hepatitis B surface antigen positive | Hepatitis C antibody positive at screening.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0201477
UMLS CUI [1,2]
C1446409
UMLS CUI [2,1]
C0201487
UMLS CUI [2,2]
C1446409
therapeutic failure on > 3 agents for psa or > 1 biologic tumor necrosis factor (tnf) blocker
Beschreibung

Therapeutic failure on > 3 agents for psa | Therapeutic failure of > 1 biologic tumor necrosis factor (tnf) blocker

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0162643
UMLS CUI [1,2]
C0003872
UMLS CUI [1,3]
C0013227
UMLS CUI [1,4]
C1265611
UMLS CUI [2,1]
C0162643
UMLS CUI [2,2]
C0281481
UMLS CUI [2,3]
C1265611
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Psoriatic Arthritis NCT01212757

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
males or females, aged ≥ 18 years at time of consent.
boolean
C0001779 (UMLS CUI [1])
Diagnosis od psoriatic arthritis, duration
Item
have a diagnosis of psoriatic arthritis (psa, by any criteria) of ≥ 6 months duration.
boolean
C0003872 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Classification criteria for psoriatic arthritis (caspar) psa.
Item
meet the classification criteria for psoriatic arthritis (caspar) psa at time of screening.
boolean
C0003872 (UMLS CUI [1,1])
C0008902 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Treatment procedure, inadequate, disease-modifying antirheumatic drugs
Item
must have been inadequately treated by disease-modifying antirheumatic drugs (dmards)
boolean
C0087111 (UMLS CUI [1,1])
C0242708 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
Not only axial involvement
Item
may not have axial involvement alone
boolean
C0475264 (UMLS CUI [1,1])
C0205131 (UMLS CUI [1,2])
C1548966 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Concurrent treatment allowed with methotrexate, leflunomide, or sulfasalazine
Item
concurrent treatment allowed with methotrexate, leflunomide, or sulfasalazine
boolean
C0025677 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0063041 (UMLS CUI [2,1])
C2347852 (UMLS CUI [2,2])
C0036078 (UMLS CUI [3,1])
C2347852 (UMLS CUI [3,2])
Swollen joints quantity, Tender joints quantity
Item
have ≥ 3 swollen and ≥ 3 tender joints.
boolean
C0152031 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0240094 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Contraceptive methods
Item
males & females must use contraception
boolean
C0700589 (UMLS CUI [1])
Stable dose of nonsteroidal anti-inflammatory drugs (nsaids), narcotics and low dose oral corticosteroids allowed.
Item
stable dose of nonsteroidal anti-inflammatory drugs (nsaids), narcotics and low dose oral corticosteroids allowed.
boolean
C0003211 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0027415 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0038317 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0445550 (UMLS CUI [3,3])
C1527415 (UMLS CUI [3,4])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast feeding.
Item
pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
History of allergy to any component of the investigational product.
Item
history of allergy to any component of the investigational product.
boolean
C0262926 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,4])
Hepatitis B surface antigen positive | Hepatitis C antibody positive at screening.
Item
hepatitis b surface antigen and/or hepatitis c antibody positive at screening.
boolean
C0201477 (UMLS CUI [1,1])
C1446409 (UMLS CUI [1,2])
C0201487 (UMLS CUI [2,1])
C1446409 (UMLS CUI [2,2])
Therapeutic failure on > 3 agents for psa | Therapeutic failure of > 1 biologic tumor necrosis factor (tnf) blocker
Item
therapeutic failure on > 3 agents for psa or > 1 biologic tumor necrosis factor (tnf) blocker
boolean
C0162643 (UMLS CUI [1,1])
C0003872 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0162643 (UMLS CUI [2,1])
C0281481 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video